A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Omeros Corp stock. As of the latest transaction made, Two Sigma Advisers, LP holds 79,000 shares of OMER stock, worth $355,500. This represents 0.0% of its overall portfolio holdings.

Number of Shares
79,000
Previous 35,200 124.43%
Holding current value
$355,500
Previous $121,000 164.46%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$3.04 - $4.23 $133,152 - $185,274
43,800 Added 124.43%
79,000 $320,000
Q1 2024

May 15, 2024

BUY
$2.88 - $4.89 $40,608 - $68,949
14,100 Added 66.82%
35,200 $121,000
Q4 2023

Feb 14, 2024

SELL
$1.08 - $3.63 $31,104 - $104,544
-28,800 Reduced 57.72%
21,100 $68,000
Q3 2023

Nov 14, 2023

BUY
$2.81 - $5.69 $31,753 - $64,297
11,300 Added 29.27%
49,900 $145,000
Q2 2023

Aug 14, 2023

SELL
$4.45 - $7.57 $173,995 - $295,987
-39,100 Reduced 50.32%
38,600 $209,000
Q1 2023

May 15, 2023

SELL
$2.48 - $5.22 $321,656 - $677,034
-129,700 Reduced 62.54%
77,700 $361,000
Q4 2022

Feb 14, 2023

SELL
$1.75 - $3.96 $56,175 - $127,116
-32,100 Reduced 13.4%
207,400 $468,000
Q3 2022

Nov 14, 2022

SELL
$3.09 - $7.46 $421,167 - $1.02 Million
-136,300 Reduced 36.27%
239,500 $754,000
Q2 2022

Aug 15, 2022

BUY
$1.92 - $6.28 $515,712 - $1.69 Million
268,600 Added 250.56%
375,800 $1.03 Million
Q1 2022

May 16, 2022

SELL
$5.07 - $7.2 $95,823 - $136,080
-18,900 Reduced 14.99%
107,200 $644,000
Q4 2021

Feb 14, 2022

SELL
$5.67 - $8.54 $241,542 - $363,803
-42,600 Reduced 25.25%
126,100 $811,000
Q3 2021

Nov 15, 2021

BUY
$13.4 - $16.3 $493,120 - $599,840
36,800 Added 27.9%
168,700 $2.33 Million
Q2 2021

Aug 16, 2021

BUY
$14.81 - $19.13 $962,650 - $1.24 Million
65,000 Added 97.16%
131,900 $1.96 Million
Q1 2021

May 17, 2021

BUY
$14.52 - $23.53 $971,388 - $1.57 Million
66,900 New
66,900 $1.19 Million
Q3 2020

Nov 16, 2020

SELL
$9.57 - $21.32 $397,155 - $884,780
-41,500 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$12.21 - $16.99 $180,708 - $251,451
14,800 Added 55.43%
41,500 $611,000
Q1 2020

May 15, 2020

BUY
$9.03 - $19.72 $241,100 - $526,524
26,700 New
26,700 $357,000
Q3 2019

Nov 14, 2019

SELL
$14.55 - $20.56 $558,720 - $789,504
-38,400 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$15.0 - $19.62 $325,500 - $425,754
-21,700 Reduced 36.11%
38,400 $602,000
Q1 2019

May 15, 2019

BUY
$11.65 - $17.72 $239,990 - $365,032
20,600 Added 52.15%
60,100 $1.04 Million
Q4 2018

Feb 14, 2019

BUY
$10.72 - $16.73 $189,744 - $296,121
17,700 Added 81.19%
39,500 $440,000
Q3 2018

Nov 14, 2018

SELL
$17.73 - $26.69 $58,509 - $88,077
-3,300 Reduced 13.15%
21,800 $532,000
Q2 2018

Aug 14, 2018

BUY
$10.79 - $24.44 $270,829 - $613,444
25,100 New
25,100 $455,000

Others Institutions Holding OMER

About OMEROS CORP


  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $282M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.